Search

Your search keyword '"Langeland, Nina"' showing total 519 results

Search Constraints

Start Over You searched for: Author "Langeland, Nina" Remove constraint Author: "Langeland, Nina"
519 results on '"Langeland, Nina"'

Search Results

501. [Can poliomyelitis be eradicated in near future?].

502. Comparison of serotyping, pulsed field gel electrophoresis and amplified fragment length polymorphism for typing of Streptococcus pneumoniae.

503. A branched, synthetic oligopeptide corresponding to a region of glycoprotein G of HSV-1 reacts sensitively and specifically with HSV-1 antibodies in an ELISA.

504. High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania.

505. Antimicrobial resistance in urinary bacterial isolates from pregnant women in rural Tanzania: implications for public health.

506. A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility.

507. Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania.

508. Nosocomial outbreak of neonatal Salmonella enterica serotype Enteritidis meningitis in a rural hospital in northern Tanzania.

509. Duplex real-time PCR assay for rapid detection of ampicillin-resistant Enterococcus faecium.

510. Lifestyle and late effects after poliomyelitis. A risk factor study of two populations.

511. Comparative analysis of amplified fragment length polymorphism and pulsed field gel electrophoresis in a hospital outbreak and subsequent endemicity of ampicillin-resistant Enterococcus faecium.

512. Population-based hematologic and immunologic reference values for a healthy Ugandan population.

513. Detection of viral sequences in archival spinal cords from fatal cases of poliomyelitis in 1951-1952.

514. Molecular characterization of ampicillin-resistant Enterococcus faecium isolates from hospitalized patients in Norway.

515. Performance characteristics of a glycoprotein G based oligopeptide (peptide 55) and two different methods using the complete glycoprotein as assays for detection of anti-HSV-2 antibodies in human sera.

516. Fcgamma receptor IIIA polymorphism as a risk factor for acute poliomyelitis.

517. Phase I trial of a therapeutic HIV type 1 vaccine, Vacc-4x, in HIV type 1-infected individuals with or without antiretroviral therapy.

518. Detection of HSV-2 in genital ulcers from STD patients in Dar es Salaam, Tanzania.

519. Long-term follow-up of patients with nonparalytic poliomyelitis.

Catalog

Books, media, physical & digital resources